OpenVSafe by OpenVAERS
Search V-safe

9H5-11394-29829

1 vaccination 1 coded response 4 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
411 / KY
Registered
2021-01-19
Relationship
Self

Timeline

  1. 2021-01-19
    Registered in v-safe
  2. 2021-01-19
    Dose 1 — Moderna
  3. 2021-01-19
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain, Redness · None
    Adult check-in
  4. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  5. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-29
    Survey response — day 7, dose 1
    MedDRA: Rhinorrhoea — Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-29
    Report sent to call center — day 7, dose 1
    Be unable to do your normal daily activities
    1 call case(s)

Vaccinations

DoseDateManufacturerCo-administered
12021-01-19Moderna

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 3 — day 7, dose 1

2021-01-29

Systemic reaction (other): Runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SRORhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release